MedPath

GLOVIA CO., LTD.

🇯🇵Japan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

2 Phases

Phase 2:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 2
1 (50.0%)

Feru-guard for Behavioral Symptoms in Dementia

Phase 2
Conditions
Behavioral and Psychiatric Symptoms of Dementia
Interventions
Other: Feru-guard 100M Placebo
Drug: Feru-guard 100M
First Posted Date
2018-03-02
Last Posted Date
2018-08-03
Lead Sponsor
Glovia Co., Ltd.
Target Recruit Count
70
Registration Number
NCT03451760

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.